References
- KrantzSBErythropoietinBlood19917734194341991159
- GlaspyJCrawfordJVansteenkisteJErythropoiesis-stimulating agents in oncology: a study-level meta-analysis of survival and other safety outcomesBr J Cancer2010102230131520051958
- BohliusJToniaTSchwarzerGTwist and shout: one decade of metaanalyses of erythropoiesis-stimulating agents in cancer patientsActa Haematol20101251–2556721150188
- PapayannopoulouTAbkowitzJD’AndreaABiology of erythropoiesis, erythroid maturation and differentiationHoffmanRBenzEJShattilSJHematology Basic Principals and Practice3rd edPhiladelphiaChurchill Livingston2000202219
- HuntJAHalf-life and rate of synthesis of globin messenger ribonucleic acid. Determination of half-life of messenger ribonucleic acid and its relative synthetic rate in erythroid cellsBiochem J197413834874984429545
- DevAFangJSathyanarayanaPPradeepAEmersonCWojchowskiDMDuring EPO or anemia challenge, erythroid progenitor cells transit through a selectively expandable proerythroblast poolBlood2010116245334534620810925
- GlaserKLimarziLRPoncherHGCellular composition of the bone marrow in normal infants and childrenPediatrics19506578982414797342
- SawyerSTKrantzSBGoldwasserEBinding and receptor-mediated endocytosis of erythropoietin in Friend virus-infected erythroid cellsJ Biol Chem198726212555455623032937
- MigliaccioGMigliaccioARVisserJWSynergism between erythropoietin and interleukin-3 in the induction of hematopoietic stem cell proliferation and erythroid burst colony formationBlood19887239449513262001
- BackxBBroedersLHoefslootLHWognumBLowenbergBErythropoiesis in myelodysplastic syndrome: expression of receptors for erythropoietin and kit ligandLeukemia19961034664728642863
- SawadaKKrantzSBDaiCHPurification of human blood burst-forming units-erythroid and demonstration of the evolution of erythropoietin receptorsJ Cell Physiol199014222192302154501
- SmithJAExercise, training and red blood cell turnoverSports Med19951919317740249
- EschbachJWThe anemia of chronic renal failure: pathophysiology and the effects of recombinant erythropoietinKidney Int19893511341482651751
- LawMLCaiGYLinFKChromosomal assignment of the human erythropoietin gene and its DNA polymorphismProc Natl Acad Sci U S A19868318692069243462737
- JacobsKShoemakerCRudersdorfRIsolation and characterization of genomic and cDNA clones of human erythropoietinNature198531360058068103838366
- LeHirMEckardtKUKaisslingBKourySTKurtzAStructure-function correlations in erythropoietin formation and oxygen sensing in the kidneyKlin Wochenschr199169135675751753679
- EschbachJWEgrieJCDowningMRBrowneJKAdamsonJWCorrection of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trialNew Engl J Med1987316273783537801
- ElliottSEgrieJBrowneJControl of rHuEPO biological activity: the role of carbohydrateExp Hematol200432121146115515588939
- EgrieJCStricklandTWLaneJCharacterization and biological effects of recombinant human erythropoietinImmunobiology19861723–52132243542810
- WickremaAKrantzSBWinkelmannJCBondurantMCDifferentiation and erythropoietin receptor gene expression in human erythroid progenitor cellsBlood1992808194019491391953
- KouryMJBondurantMCErythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cellsScience199024849533783812326648
- RogersHMYuXWenJSmithRFibachENoguchiCTHypoxia alters progression of the erythroid programExp Hematol2008361172717936496
- WangGLJiangBHRueEASemenzaGLHypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tensionProc Natl Acad Sci U S A19959212551055147539918
- JiangBHRueEWangGLRoeRSemenzaGLDimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1J Biol Chem19962713017771177788663540
- RankinEBBijuMPLiuQHypoxia-inducible factor-2 (HIF-2) regulates hepatic erythropoietin in vivoJ Clin Invest200711741068107717404621
- YamashitaTOhnedaOSakiyamaAIwataFOhnedaKFujii-KuriyamaYThe microenvironment for erythropoiesis is regulated by HIF-2alpha through VCAM-1 in endothelial cellsBlood200811241482149218451309
- KapitsinouPPLiuQUngerTLHepatic HIF-2 regulates erythropoietic responses to hypoxia in renal anemiaBlood2010116163039304820628150
- PaliegeARosenbergerCBondkeAHypoxia-inducible factor- 2alpha-expressing interstitial fibroblasts are the only renal cells that express erythropoietin under hypoxia-inducible factor stabilizationKidney Int201077431231820016470
- EpsteinACGleadleJMMcNeillLAC. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylationCell20011071435411595184
- MassonNWillamCMaxwellPHPughCWRatcliffePJIndependent function of two destruction domains in hypoxia-inducible factor-alpha chains activated by prolyl hydroxylationEMBO J200120185197520611566883
- BruickRKMcKnightSLA conserved family of prolyl-4-hydroxylases that modify HIFScience200129455451337134011598268
- IvanMKondoKYangHHIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensingScience2001292551646446811292862
- HonWCWilsonMIHarlosKStructural basis for the recognition of hydroxyproline in HIF-1 alpha by pVHLNature2002417689297597812050673
- MaxwellPHPughCWRatcliffePJInsights into the role of the von Hippel-Lindau gene product. A key player in hypoxic regulationExp Nephrol20019423524011423722
- KourySTKouryMJBondurantMCCaroJGraberSEQuantitation of erythropoietin-producing cells in kidneys of mice by in situ hybridization: correlation with hematocrit, renal erythropoietin mRNA, and serum erythropoietin concentrationBlood19897426456512752138
- ObaraNSuzukiNKimKNagasawaTImagawaSYamamotoMRepression via the GATA box is essential for tissue-specific erythropoietin gene expressionBlood2008111105223523218202227
- ErslevAJWilsonJCaroJErythropoietin titers in anemic, nonuremic patientsJ Lab Clin Med198710944294333102659
- LinCSLimSKD’AgatiVCostantiniFDifferential effects of an erythropoietin receptor gene disruption on primitive and definitive erythropoiesisGenes Dev19961021541648566749
- MizunoSSasakiJSuzukiCKonoHKojimaSEffect of recombinant human erythropoietin administration on peripheral blood neutrophil counts of premature infantsJ Pediatr199412434674708120723
- ShannonKMMentzerWCAbelsRIRecombinant human erythropoietin in the anemia of prematurity: results of a placebo-controlled pilot studyJ Pediatr199111869499552040933
- WardCSWestwoodNBEmmersonAJPearsonTCThe in vitro effect of high-dose recombinant human erythropoietin on granulocyte-macrophage colony production in premature infants using a defined serum deprived cell culture systemBr J Haematol19928133253301382542
- UlichTRdelCJYinSMEgrieJCThe erythropoietic effects of interleukin 6 and erythropoietin in vivoExp Hematol199119129341989892
- SingbrantSRussellMRJovicTErythropoietin couples erythropoiesis, B-lymphopoiesis, and bone homeostasis within the bone marrow microenvironmentBlood2011117215631564221421837
- RamsfjellVBorgeOJVeibyOPThrombopoietin, but not erythropoietin, directly stimulates multilineage growth of primitive murine bone marrow progenitor cells in synergy with early acting cytokines: distinct interactions with the ligands for c-kit and FLT3Blood19968812448144928977240
- MadanALinCWangZCurtinPTAutocrine stimulation by erythropoietin in transgenic mice results in erythroid proliferation without neoplastic transformationBlood Cells Mol Dis2003301828912667989
- FurukawaTNaritaMSakaueMPrimary familial polycythaemia associated with a novel point mutation in the erythropoietin receptorBr J Haematol19979912222279359528
- SherwoodJBThe chemistry and physiology of erythropoietinVitam Horm1984411612116397910
- JelkmannWErythropoietin: structure, control of production, and functionPhysiol Rev19927224494891557429
- BeruNMcDonaldJLacombeCGoldwasserEExpression of the erythropoietin geneMol Cell Biol198667257125753466025
- BachmannSLeHMEckardtKUCo-localization of erythropoietin mRNA and ecto-5′-nucleotidase immunoreactivity in peritubular cells of rat renal cortex indicates that fibroblasts produce erythropoietinJ Histochem Cytochem19934133353418429197
- MaxwellPHOsmondMKPughCWIdentification of the renal erythropoietin-producing cells using transgenic miceKidney Int1993445114911628264149
- TanCCEckardtKURatcliffePJOrgan distribution of erythropoietin messenger RNA in normal and uremic ratsKidney Int199140169761921157
- SemenzaGLKourySTNejfeltMKGearhartJDAntonarakisSECell-type-specific and hypoxia-inducible expression of the human erythropoietin gene in transgenic miceProc Natl Acad Sci U S A19918819872587291924331
- FandreyJBunnHFIn vivo and in vitro regulation of erythropoietin mRNA: measurement by competitive polymerase chain reactionBlood19938136176238381307
- SuzukiNObaraNYamamotoMUse of gene-manipulated mice in the study of erythropoietin gene expressionMethods Enzymol200743515717717998054
- DavidRBLimGBMoritzKMKoukoulasIWintourEMQuantitation of the mRNA levels of Epo and EpoR in various tissues in the ovine fetusMol Cell Endocrinol20021881–220721811911958
- BondurantMCKouryMJKourySTSemenzaGErythropoietin ontogeny and organ distribution in miceSemin Hematol1991283 Suppl 320251891721
- ErslevAJCaroJKansuESilverRRenal and extrarenal erythropoietin production in anaemic ratsBr J Haematol198045165727378330
- BondurantMCKouryMJAnemia induces accumulation of erythropoietin mRNA in the kidney and liverMol Cell Biol198667273127333785209
- EckardtKURatcliffePJTanCCBauerCKurtzAAge-dependent expression of the erythropoietin gene in rat liver and kidneysJ Clin Invest19928937537601541670
- KourySTBondurantMCKouryMJSemenzaGLLocalization of cells producing erythropoietin in murine liver by in situ hybridizationBlood19917711249725032039831
- FredeSFreitagPGeutingLKonietznyRFandreyJOxygen-regulated expression of the erythropoietin gene in the human renal cell line REPCBlood2011117184905491421406725
- LoyaFYangYLinHGoldwasserEAlbitarMTransgenic mice carrying the erythropoietin gene promoter linked to lacZ express the reporter in proximal convoluted tubule cells after hypoxiaBlood1994846183118368080988
- JeongJYFeldmanLSolarPSzenajchJSytkowskiAJCharacterization of erythropoietin receptor and erythropoietin expression and function in human ovarian cancer cellsInt J Cancer2008122227428017893874
- JeongJYHoxhajGSochaALSytkowskiAJFeldmanLAn erythropoietin autocrine/paracrine axis modulates the growth and survival of human prostate cancer cellsMol Cancer Res2009771150115719567780
- AcsGZhangPJRebbeckTRAcsPVermaAImmunohistochemical expression of erythropoietin and erythropoietin receptor in breast carcinomaCancer200295596998112209679
- GombosZDanihelLRepiskaVAcsGFurthEExpression of erythropoietin and its receptor increases in colonic neoplastic progression: the role of hypoxia in tumorigenesisIndian J Pathol Microbiol201154227327821623073
- SanchezPENavarroFPFaresRPErythropoietin receptor expression is concordant with erythropoietin but not with common beta chain expression in the rat brain throughout the life spanJ Comp Neurol2009514440341419330822
- Castillo-MelendezMYanEWalkerDWExpression of erythropoietin and its receptor in the brain of late-gestation fetal sheep, and responses to asphyxia caused by umbilical cord occlusionDev Neurosci2005272–422022716046857
- ChungYHKimSIJooKMAge-related changes in erythropoietin immunoreactivity in the cerebral cortex and hippocampus of ratsBrain Res20041018114114615262216
- KnabeWKnerlichFWashausenSExpression patterns of erythropoietin and its receptor in the developing midbrainAnat Embryol (Berl)2004207650351214770308
- WinkelmannJCPennyLADeavenLLForgetBGJenkinsRBThe gene for the human erythropoietin receptor: analysis of the coding sequence and assignment to chromosome 19pBlood199076124302163695
- JonesSSD’AndreaADHainesLLWongGGHuman erythropoietin receptor: cloning, expression, and biologic characterizationBlood199076131352163696
- D’AndreaADLodishHFWongGGExpression cloning of the murine erythropoietin receptorCell19895722772852539263
- BudarfMHuebnerKEmanuelBAssignment of the erythropoietin receptor (EPOR) gene to mouse chromosome 9 and human chromosome 19Genomics1990835755781962754
- ElliottSBusseLBassMBAnti-Epo receptor antibodies do not predict Epo receptor expressionBlood200610751892189516249375
- AtkinsHLBroudyVCPapayannopoulouTCharacterization of the structure of the erythropoietin receptor by ligand blottingBlood19917712257725821646043
- ElliottSBusseLMcCafferyIIdentification of a sensitive antierythropoietin receptor monoclonal antibody allows detection of low levels of EpoR in cellsJ Immunol Methods201035212613919887071
- KettelerRHeinrichACOffeJKA functional green fluorescent protein-erythropoietin receptor despite physical separation of JAK2 binding site and tyrosine residuesJ Biol Chem200227729265472655211997394
- SwiftSEllisonARKassnerPAbsence of functional EpoR expression in human tumor cell linesBlood2010115214254426320124514
- NeumannDWikstromLWatowichSSLodishHFIntermediates in degradation of the erythropoietin receptor accumulate and are degraded in lysosomesJ Biol Chem19932681813639136498514796
- HiltonDJWatowichSSMurrayPJLodishHFIncreased cell surface expression and enhanced folding in the endoplasmic reticulum of a mutant erythropoietin receptorProc Natl Acad Sci U S A19959211901947816815
- Supino-RosinLYoshimuraAAltaratzHNeumannDA cytosolic domain of the erythropoietin receptor contributes to endoplasmic reticulum-associated degradationEur J Biochem1999263241041910406949
- BilliaFBarbaraMMcEwenJTrevisanMIscoveNNResolution of pluripotential intermediates in murine hematopoietic differentiation by global complementary DNA amplification from single cells: confirmation of assignments by expression profiling of cytokine receptor transcriptsBlood20019782257226811290586
- LiuZYChinKNoguchiCTTissue specific expression of human erythropoietin receptor in transgenic miceDev Biol199416611591697958443
- ChibaTIkawaYTodokoroKGATA-1 transactivates erythropoietin receptor gene, and erythropoietin receptor-mediated signals enhance GATA-1 gene expressionNucleic Acids Res19911914384338481650452
- HeberleinCFischerKDStoffelMThe gene for erythropoietin receptor is expressed in multipotential hematopoietic and embryonal stem cells: evidence for differentiation stage-specific regulationMol Cell Biol1992124181518261312671
- HeinrichACPelandaRKlingmullerUA mouse model for visualization and conditional mutations in the erythroid lineageBlood2004104365966615090451
- AshiharaEVannucchiAMMigliaccioGMigliaccioARGrowth factor receptor expression during in vitro differentiation of partially purified populations containing murine stem cellsJ Cell Physiol199717133433569180904
- ChibaSTakahashiTTakeshitaKSelective expression of mRNA coding for the truncated form of erythropoietin receptor in hematopoietic cells and its decrease in patients with polycythemia veraBlood1997901971049207443
- LaugschMMetzenESvenssonTDeppingRJelkmannWLack of functional erythropoietin receptors of cancer cell linesInt J Cancer200812251005101117990315
- SinclairAMRogersNBusseLErythropoietin receptor transcription is neither elevated nor predictive of surface expression in human tumour cellsBr J Cancer20089861059106718349818
- KellerMAAddyaSVadigepalliRTranscriptional regulatory network analysis of developing human erythroid progenitors reveals patterns of coregulation and potential transcriptional regulatorsPhysiol Genomics200628111412816940433
- SinclairAMCoxonAMcCafferyIFunctional erythropoietin receptor is undetectable in endothelial, cardiac, neuronal, and renal cellsBlood2010115214264427220124513
- HardeeMEArcasoyMOBlackwellKLKirkpatrickJPDewhirstMWErythropoietin biology in cancerClin Cancer Res200612233233916428469
- KokhaeiPAbdallaAOHanssonLExpression of erythropoietin receptor and in vitro functional effects of epoetins in B-cell malignanciesClin Cancer Res200713123536354417575216
- BrownWMMaxwellPGrahamANErythropoietin receptor expression in non-small cell lung carcinoma: a question of antibody specificityStem Cells200725371872217110616
- KirkebyAvanBJNielsenJLeistMHelboeLFunctional and immunochemical characterisation of different antibodies against the erythropoietin receptorJ Neurosci Methods20071641505817524492
- SinclairAMToddMDForsytheKKnoxSJElliottSBegleyCGExpression and function of erythropoietin receptors in tumors: implications for the use of erythropoiesis-stimulating agents in cancer patientsCancer2007110347748817582631
- OsterborgAAaproMCornesPHaselbeckAHaywardCRJelkmannWPreclinical studies of erythropoietin receptor expression in tumour cells: impact on clinical use of erythropoietic proteins to correct cancer-related anaemiaEur J Cancer200743351051917150352
- KirkpatrickPSpecificity concerns with antibodies for receptor mappingNat Rev Drug Discov20098427819348032
- BordeauxJWelshAAgarwalSAntibody validationBiotechniques201048319720920359301
- BroudyVCLinNEgrieJIdentification of the receptor for erythropoietin on human and murine erythroleukemia cells and modulation by phorbol ester and dimethyl sulfoxideProc Natl Acad Sci U S A19888517651365172842774
- BroudyVCLinNBriceMNakamotoBPapayannopoulouTErythropoietin receptor characteristics on primary human erythroid cellsBlood19917712258325901646044
- RadinskyRRisinSFanDLevel and function of epidermal growth factor receptor predict the metastatic potential of human colon carcinoma cellsClin Cancer Res19951119319815883
- FoonKAYangXDWeinerLMPreclinical and clinical evaluations of ABX-EGF, a fully human anti-epidermal growth factor receptor antibodyInt J Radiat Oncol Biol Phys200458398499014967460
- SasakiRYanagawaSHitomiKChibaHCharacterization of erythropoietin receptor of murine erythroid cellsEur J Biochem1987168143482822405
- McArthurGALongmoreGDKlinglerKJohnsonGRLineage-restricted recruitment of immature hematopoietic progenitor cells in response to Epo after normal hematopoietic cell transfection with EpoRExp Hematol19952376456547601257
- SawadaKKrantzSBSawyerSTCivinCIQuantitation of specific binding of erythropoietin to human erythroid colony-forming cellsJ Cell Physiol198813723373453192618
- WognumAWLansdorpPMHumphriesRKKrystalGDetection and isolation of the erythropoietin receptor using biotinylated erythropoietinBlood19907646977052166605
- WognumAWKrystalGEavesCJEavesACLansdorpPMIncreased erythropoietin-receptor expression on CD34-positive bone marrow cells from patients with chronic myeloid leukemiaBlood19927936426491370638
- ShinjoKTakeshitaAHiguchiMOhnishiKOhnoRErythropoietin receptor expression on human bone marrow erythroid precursor cells by a newly-devised quantitative flow-cytometric assayBr J Haematol19979635515589054663
- MayeuxPBillatCJacquotRThe erythropoietin receptor of rat erythroid progenitor cells. Characterization and affinity cross-linkageJ Biol Chem19872622913985139902820989
- HoshinoSTeramuraMTakahashiMExpression and characterization of erythropoietin receptors on normal human bone marrow cellsInt J Cell Cloning1989731561672543713
- FraserJKLinFKBerridgeMVExpression of high affinity receptors for erythropoietin on human bone marrow cells and on the human erythroleukemic cell line, HELExp Hematol198816108368422844573
- WuHLiuXJaenischRLodishHFGeneration of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptorCell199583159677553874
- MitjavilaMTNatazawaMBrignaschiPDebiliNBreton-GoriusJVainchenkerWEffects of five recombinant hematopoietic growth factors on enriched human erythroid progenitors in serum-replaced culturesJ Cell Physiol198913836176232647773
- CullVTilbrookPAAdenanASDominant action of mutated erythropoietin receptors on differentiation in vitro and erythroleukemia development in vivoOncogene200019795396010702804
- HuangLJConstantinescuSNLodishHFThe N-terminal domain of Janus kinase 2 is required for Golgi processing and cell surface expression of erythropoietin receptorMol Cell2001861327133811779507
- WickremaABondurantMCKrantzSBAbundance and stability of erythropoietin receptor mRNA in mouse erythroid progenitor cellsBlood1991789226922751657247
- LodishHFHiltonDLongmoreGWatowichSSYoshimuraAThe erythropoietin receptor: dimerization, activation, and tumorigenesisCold Spring Harb Symp Quant Biol199257951061339709
- YoussoufianHZonLIOrkinSHD’AndreaADLodishHFStructure and transcription of the mouse erythropoietin receptor geneMol Cell Biol1990107367536822162479
- ZonLIYoussoufianHMatherCLodishHFOrkinSHActivation of the erythropoietin receptor promoter by transcription factor GATA-1Proc Natl Acad Sci U S A1991882310638106411660143
- MaoucheLCartronJPChretienSDifferent domains regulate the human erythropoietin receptor gene transcriptionNucleic Acids Res19942233383468127671
- YoussoufianHFurther characterization of cis-acting regulatory sequences in the genomic locus of the murine erythropoietin receptor: evidence for stage-specific regulationBlood1994835142814358118044
- KuramochiSIkawaYTodokoroKCharacterization of murine erythropoietin receptor genesJ Mol Biol199021635675752175360
- SingbrantSRussellMRJovicErythropoietin couples erythropoiesis, B lymphopoiesis, and bone homeostasis within the bone marrow microenvironmentBlood2011117215631564221421837
- HagstromLAgbulutOEl-Hasnaoui-SaadaniREpo is relevant neither for microvascular formation nor for the new formation and maintenance of mice skeletal muscle fibres in both normoxia and hypoxiaJ Biomed Biotechnol2010201013781720414335
- BanerjeeDRodriguezMNagMAdamsonJWExposure of endothelial cells to recombinant human erythropoietin induces nitric oxide synthase activityKidney Int20005751895190410792608
- OhigashiTYoshiokaKFisherJWAutocrine regulation of erythropoietin gene expression in human hepatocellular carcinoma cellsLife Sci19965854214278594307
- DigicayliogluMBichetSMartiHHLocalization of specific erythropoietin binding sites in defined areas of the mouse brainProc Natl Acad Sci U S A1995929371737207731971
- MohyeldinADalgardCLLuHSurvival and invasiveness of astrocytomas promoted by erythropoietinJ Neurosurg2007106233835017410721
- BrameyTFreitagPFandreyJNo evidence for protective erythropoietin alpha signalling in rat hepatocytesBMC Gastroenterol200992619383129
- WinterSCShahKACampoLRelation of erythropoietin and erythropoietin receptor expression to hypoxia and anemia in head and neck squamous cell carcinomaClin Cancer Res200511217614762016278379
- BernaudinMBellailAMartiHHNeurons and astrocytes express EPO mRNA: oxygen-sensing mechanisms that involve the redox-state of the brainGlia200030327127810756076
- WincewiczAKodaMSulkowskaMKanczuga-KodaLWincewiczDSulkowskiSSTAT3 and hypoxia induced proteins – HIF-1alpha, EPO and EPOR in relation with Bax and Bcl-xL in nodal metastases of ductal breast cancersFolia Histochem Cytobiol200947342543020164027
- BatraSPerelmanNLuckLRShimadaHMalikPPediatric tumor cells express erythropoietin and a functional erythropoietin receptor that promotes angiogenesis and tumor cell survivalLab Invest200383101477148714563949
- LamSYTipoeGLFungMLUpregulation of erythropoietin and its receptor expression in the rat carotid body during chronic and intermittent hypoxiaAdv Exp Med Biol200964820721419536483
- ChenZYWangLAsavaritkraiPNoguchiCTUp-regulation of erythropoietin receptor by nitric oxide mediates hypoxia preconditioningJ Neurosci Res201088143180318820806411
- AcsGAcsPBeckwithSMErythropoietin and erythropoietin receptor expression in human cancerCancer Res20016193561356511325818
- PevnyLLinCSD’AgatiVSimonMCOrkinSHCostantiniFDevelopment of hematopoietic cells lacking transcription factor GATA-1Development199512111631727867497
- PevnyLSimonMCRobertsonEErythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1Nature199134963062572601987478
- SimonMCPevnyLWilesMVKellerGCostantiniFOrkinSHRescue of erythroid development in gene targeted GATA-1- mouse embryonic stem cellsNat Genet19921292981302015
- KomatsuNKiritoKKashiiYCell-cycle-dependent regulation of erythropoietin receptor geneBlood1997894118211889028940
- SuzukiNSuwabeNOhnedaOIdentification and characterization of 2 types of erythroid progenitors that express GATA-1 at distinct levelsBlood2003102103575358312893747
- CrottaSNicolisSRonchiAProgressive inactivation of the expression of an erythroid transcriptional factor in GM- and G-CSF-dependent myeloid cell linesNucleic Acids Res19901823686368691702202
- MigliaccioARMigliaccioGD’AndreaAResponse to erythropoietin in erythroid subclones of the factor-dependent cell line 32D is determined by translocation of the erythropoietin receptor to the cell surfaceProc Natl Acad Sci U S A1991882411086110901722318
- TsangAPFujiwaraYHomDBOrkinSHFailure of megakaryopoiesis and arrested erythropoiesis in mice lacking the GATA-1 transcriptional cofactor FOGGenes Dev1998128117611889553047
- SnowJWOrkinSHTranslational isoforms of FOG1 regulate GATA1- interacting complexesJ Biol Chem200928443293102931919654328
- KassoufMTHughesJRTaylorSGenome-wide identification of TAL1’s functional targets: insights into its mechanisms of action in primary erythroid cellsGenome Res20102081064108320566737
- MikkolaHKKlintmanJYangHHaematopoietic stem cells retain long-term repopulating activity and multipotency in the absence of stem-cell leukaemia SCL/tal-1 geneNature2003421692254755112540851
- GreenARSalvarisEBegleyCGErythroid expression of the ‘helix-loop- helix’ gene, SCLOncogene1991634754792011404
- VisvaderJBegleyCGAdamsJMDifferential expression of the LYL, SCL and E2 A helix-loop-helix genes within the hemopoietic systemOncogene1991621871942000219
- InthalAKrapfGBeckDRole of the erythropoietin receptor in ETV6/RUNX1-positive acute lymphoblastic leukemiaClin Cancer Res200814227196720419010836
- GreenARLintsTVisvaderJHarveyRBegleyCGSCL is coexpressed with GATA-1 in hemopoietic cells but is also expressed in developing brainOncogene1992746536601565464
- MaoucheLCartronJPChretienSDifferent domains regulate the human erythropoietin receptor gene transcriptionNucleic Acids Res19942233383468127671
- NoguchiCTBaeKSChinKWadaYSchechterANHankinsWDCloning of the human erythropoietin receptor geneBlood19917810254825561668606
- PhiloJSAokiKHArakawaTNarhiLOWenJDimerization of the extracellular domain of the erythropoietin (EPO) receptor by EPO: one high-affinity and one low-affinity interactionBiochemistry1996355168116918634300
- SyedRSReidSWLiCEfficiency of signalling through cytokine receptors depends critically on receptor orientationNature199839567015115169774108
- WatowichSSActivation of erythropoietin signaling by receptor dimerizationInt J Biochem Cell Biol199931101075108810582340
- GrossAWLodishHFCellular trafficking and degradation of erythropoietin and novel erythropoiesis stimulating protein (NESP)J Biol Chem200628142024203216286456
- BeckmanDLLinLLQuinonesMELongmoreGDActivation of the erythropoietin receptor is not required for internalization of bound erythropoietinBlood19999482667267510515870
- NarhiLOAokiKHPhiloJSArakawaTChanges in conformation and stability upon formation of complexes of erythropoietin (EPO) and soluble EPO receptorJ Protein Chem19971632132259155092
- RemyIWilsonIAMichnickSWErythropoietin receptor activation by a ligand-induced conformation changeScience199928354049909939974393
- LuXGrossAWLodishHFActive conformation of the erythropoietin receptor: random and cysteine-scanning mutagenesis of the extracellular juxtamembrane and transmembrane domainsJ Biol Chem2006281117002701116414957
- WojchowskiDMGregoryRCMillerCPPanditAKPircherTJSignal transduction in the erythropoietin receptor systemExp Cell Res1999253114315610579919
- JegalianAGWuHDifferential roles of SOCS family members in EpoR signal transductionJ Interferon Cytokine Res200222885386012396724
- MinooPZadehMMRottapelRLebrunJJAliSA novel SHP-1/ Grb2-dependent mechanism of negative regulation of cytokine-receptor signaling: contribution of SHP-1 C-terminal tyrosines in cytokine signalingBlood200410341398140714551136
- VerdierFWalrafenPHubertNProteasomes regulate the duration of erythropoietin receptor activation by controlling down-regulation of cell surface receptorsJ Biol Chem200027524183751838110849444
- KubatzkyKFRuanWGurezkaRSelf assembly of the transmembrane domain promotes signal transduction through the erythropoietin receptorCurr Biol200111211011511231127
- BinderCLafayetteAArchibequeIOptimization and utilization of the SureFire phospho-STAT5 assay for a cell-based screening campaignAssay Drug Dev Technol200861273718336085
- TakahashiTChibaSHiranoNYazakiYHiraiHCharacterization of three erythropoietin (Epo)-binding proteins in various human Eporesponsive cell lines and in cells transfected with human Epo-receptor cDNABlood19958511061147803787
- SantucciMAPierceJHZanniniSErythropoietin increases the radioresistance of a clonal hematopoietic progenitor cell line expressing a transgene for the erythropoietin receptorStem Cells19941255065137804124
- YawataHYasukawaKNatsukaSStructure-function analysis of human IL-6 receptor: dissociation of amino acid residues required for IL-6-binding and for IL-6 signal transduction through gp130EMBO J1993124170517128467812
- JegalianAGAcurioADranoffGWuHErythropoietin receptor haploinsufficiency and in vivo interplay with granulocytemacrophage colony-stimulating factor and interleukin 3Blood20029972603260511895800
- UmMGrossAWLodishHFA “classical” homodimeric erythropoietin receptor is essential for the antiapoptotic effects of erythropoietin on differentiated neuroblastoma SH-SY5Y and pheochromocytoma PC-12 cellsCell Signal200719363464517045782
- PregiNVittoriDPerezGLeirosCPNesseAEffect of erythropoietin on staurosporine-induced apoptosis and differentiation of SH-SY5Y neuroblastoma cellsBiochim Biophys Acta20061763223824616500719
- RosslerJStolzeIFredeSHypoxia-induced erythropoietin expression in human neuroblastoma requires a methylation free HIF-1 binding siteJ Cell Biochem200493115316115352172
- DrexlerHGMatsuoYMacLeodRAMalignant hematopoietic cell lines: in vitro models for the study of erythroleukemiaLeuk Res200428121243125115475063
- TodokoroKKanazawaSAmanumaHIkawaYCharacterization of erythropoietin receptor on erythropoietin-unresponsive mouse erythroleukemia cellsBiochim Biophys Acta198894323263302840960
- MayeuxPBillatCJacquotRMurine erythroleukaemia cells (Friend cells) possess high-affinity binding sites for erythropoietinFEBS Lett198721122292333467981
- EhrenmanKStJTThe erythropoietin receptor gene: cloning and identification of multiple transcripts in an erythroid cell line OCIM1Exp Hematol19911999739771654273
- ZouXCalameKSignaling pathways activated by oncogenic forms of Abl tyrosine kinaseJ Biol Chem199927426181411814410373409
- LozzioCBLozzioBBHuman chronic myelogenous leukemia cell-line with positive Philadelphia chromosomeBlood1975453321334163658
- ElliottSBusseLSwiftSLack of expression and function of erythropoietin receptors in kidneyNephrol Dial Transplant2012 Epub December 13, 2011
- GaffenSLLaiSYLongmoreGDLiuKDGoldsmithMAGenetic evidence for an additional factor required for erythropoietin-induced signal transductionBlood1999941748610381500
- D’AndreaADJonesSSActivation of the erythropoietin receptor in stable lymphoid and myeloid transfectantsSemin Hematol19912821521571652158
- ShikamaYBarberDLD’AndreaADSieffCAA constitutively activated chimeric cytokine receptor confers factor-independent growth in hematopoietic cell linesBlood19968824554648695792
- WakaoHHaradaNKitamuraTMuiALMiyajimaAInterleukin 2 and erythropoietin activate STAT5/MGF via distinct pathwaysEMBO J19951411252725357781605
- YamamuraYKageyamaYMatuzakiTNodaMIkawaYDistinct downstream signaling mechanism between erythropoietin receptor and interleukin-2 receptorEMBO J19921113490949151464316
- MinamotoSTreismanJHankinsWDSugamuraKRosenbergSAAcquired erythropoietin responsiveness of interleukin-2- dependent T lymphocytes retrovirally transduced with genes encoding chimeric erythropoietin/interleukin-2 receptorsBlood1995866228122877662975
- LongmoreGDLodishHFAn activating mutation in the murine erythropoietin receptor induces erythroleukemia in mice: a cytokine receptor superfamily oncogeneCell1991676108911021662116
- KangJKChangCHNamHJDownregulation of erythropoietin receptor by overexpression of phospholipase C-gamma 1 is critical for decrease on focal adhesion in transformed cellsCell Oncol20113411121
- LayonMEAckleyCJWestRJLowreyCHExpression of GATA-1 in a non-hematopoietic cell line induces beta-globin locus control region chromatin structure remodeling and an erythroid pattern of gene expressionJ Mol Biol2007366373774417196618
- MiuraYMiuraOIhleJNAokiNActivation of the mitogen-activated protein kinase pathway by the erythropoietin receptorJ Biol Chem19942694729962299697961995
- ZhanXGoldfarbMGrowth factor requirements of oncogene-transformed NIH 3T3 and BALB/c 3T3 cells cultured in defined mediaMol Cell Biol1986610354135443796592
- PharrPNOgawaMHofbauerALongmoreGDExpression of an activated erythropoietin or a colony-stimulating factor 1 receptor by pluripotent progenitors enhances colony formation but does not induce differentiationProc Natl Acad Sci U S A19949116748274868052607
- LongmoreGDPharrPNeumannDLodishHFBoth megakaryocytopoiesis and erythropoiesis are induced in mice infected with a retrovirus expressing an oncogenic erythropoietin receptorBlood1993828238623958400289
- LongmoreGDPharrPNLodishHFA constitutively activated erythropoietin receptor stimulates proliferation and contributes to transformation of multipotent, committed nonerythroid and erythroid progenitor cellsMol Cell Biol1994144226622778139532
- HenkeMLaszigRRubeCErythropoietin to treat head and neck cancer patients with anaemia undergoing radiotherapy: randomised, double-blind, placebo-controlled trialLancet200336293921255126014575968
- HenkeMMatternDPepeMDo erythropoietin receptors on cancer cells explain unexpected clinical findings?J Clin Oncol200624294708471317028293
- McKinneyMArcasoyMOErythropoietin for oncology supportive careExp Cell Res20113179 Special Issue SI1246125421396935
- SzenajchJWcisloGJeongJYSzczylikCFeldmanLThe role of erythropoietin and its receptor in growth, survival and therapeutic response of human tumor cells. From clinic to bench – a critical reviewBiochim Biophys Acta201018061829520406667
- JelkmannWBohliusJHallekMSytkowskiAJThe erythropoietin receptor in normal and cancer tissuesCrit Rev Oncol Hematol2008671396118434185
- NowrousianMRDunstJVaupelPErythropoiesis-stimulating agents: favorable safety profile when used as indicatedStrahlenther Onkol2008184312113618330508
- HadlandBKLongmoreGDErythroid-stimulating agents in cancer therapy: potential dangers and biologic mechanismsJ Clin Oncol2009254217422619636005
- WinkelmannJCWardJMayeuxPLacombeCSchimmentiLJenkinsRBA translocated erythropoietin receptor gene in a human erythroleukemia cell line (TF-1) expresses an abnormal transcript and a truncated proteinBlood19958511791857803793
- ChretienSMoreau-GachelinFApiouFPutative oncogenic role of the erythropoietin receptor in murine and human erythroleukemia cellsBlood1994837181318218142650
- GondaTJD’AndreaRJActivating mutations in cytokine receptors: implications for receptor function and role in diseaseBlood19978923553699002936
- Le CouedicJPMitjavilaMTVillevalJLMissense mutation of the erythropoietin receptor is a rare event in human erythroid malignanciesBlood1996874150215118608241
- D’AndreaADMoreauJFShowersMOMolecular mimicry of erythropoietin by the spleen focus-forming virus gp55 glycoprotein: the first stage of Friend virus-induced erythroleukemiaBiochim Biophys Acta19921114131411390869
- Moreau-GachelinFMulti-stage Friend murine erythroleukemia: molecular insights into oncogenic cooperationRetrovirology200859918983647
- YoshimuraALongmoreGLodishHFPoint mutation in the exoplasmic domain of the erythropoietin receptor resulting in hormone-independent activation and tumorigenicityNature199034863026476492174515
- RivesSPahlHLFlorensaLMolecular genetic analyses in familial and sporadic congenital primary erythrocytosisHaematologica200792567467717488692
- Al-SheikhMMazurierEGardieBA study of 36 unrelated cases with pure erythrocytosis revealed three new mutations in the erythropoietin receptor geneHaematologica20089371072107518492694
- WatowichSSXieXKlingmullerUErythropoietin receptor mutations associated with familial erythrocytosis cause hypersensitivity to erythropoietin in the heterozygous stateBlood19999472530253210498627
- de la ChapelleATraskelinALJuvonenETruncated erythropoietin receptor causes dominantly inherited benign human erythrocytosisProc Natl Acad Sci U S A19939010449544998506290
- GordeukVRSergueevaAIMiasnikovaGYCongenital disorder of oxygen sensing: association of the homozygous Chuvash polycythemia VHL mutation with thrombosis and vascular abnormalities but not tumorsBlood2004103103924393214726398
- AcsGZhangPJMcGrathCMHypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progressionAm J Pathol200316261789180612759237
- ArcasoyMOJiangXHaroonZAExpression of erythropoietin receptor splice variants in human cancerBiochem Biophys Res Commun20033074999100712878211
- BatraSPerelmanNLuckLRShimadaHMalikPPediatric tumor cells express erythropoietin and a functional erythropoietin receptor that promotes angiogenesis and tumor cell survivalLab Invest200383101477148714563949
- FeldmanLWangYRhimJSBhattacharyaNLodaMSytkowskiAJErythropoietin stimulates growth and STAT5 phosphorylation in human prostate epithelial and prostate cancer cellsProstate200666213514516161153
- KataokaMMoriyaYMoriguchiYEffect of erythropoietin on human tumor growth in xenograft modelsMol Med Report2010319510121472206
- LaiSYChildsEEXiSErythropoietin-mediated activation of JAK-STAT signaling contributes to cellular invasion in head and neck squamous cell carcinomaOncogene200524274442444915856028
- LarssonAMJirstromKFredlundEErythropoietin receptor expression and correlation to tamoxifen response and prognosis in breast cancerClin Cancer Res200915175552555919706814
- WestphalGNiederbergerEBlumCErythropoietin and G-CSF receptors in human tumor cells: expression and aspects regarding functionalityTumori200288215015912088257
- YasudaYFujitaYMatsuoTErythropoietin regulates tumour growth of human malignanciesCarcinogenesis20032461021102912807756
- YasudaYFujitaYMasudaSErythropoietin is involved in growth and angiogenesis in malignant tumours of female reproductive organsCarcinogenesis200223111797180512419827
- ShiZHodgesVMDunlopEAErythropoietin-induced activation of the JAK2/STAT5, PI3K/Akt, and Ras/ERK pathways promotes malignant cell behavior in a modified breast cancer cell lineMol Cancer Res20108461562620353997
- MillerCPloweKAValliant-SaundersKEvaluating erythropoietin- associated tumor progression using archival tissues from a phase III clinical trialStem Cells20092792353236119544471
- NingSHartleyCMolineuxGKnoxSJDarbepoietin alfa potentiates the efficacy of radiation therapy in mice with corrected or uncorrected anemiaCancer Res200565128429015665305
- ParaghGKumarSMRakosyZChoiSCXuXAcsGRNA interference-mediated inhibition of erythropoietin receptor expression suppresses tumor growth and invasiveness in A2780 human ovarian carcinoma cellsAm J Pathol200917441504151419264915
- SasakiYKjellenEMinetaHWennerbergJEkbladLNo direct effects of erythropoietin beta on a head and neck squamous cell carcinoma cell line which is growth stimulated in vivoActa Oncol20094871062106919412811
- WilliamsDMZimmersTAPierceJHThe expression and role of human erythropoietin receptor in erythroid and nonerythroid cellsAnn N Y Acad Sci19947182322437514379
- MasudaSNagaoMTakahataKFunctional erythropoietin receptor of the cells with neural characteristics. Comparison with receptor properties of erythroid cellsJ Biol Chem19932681511208112167684373
- SaintignyPBesseBCallardPErythropoietin and erythropoietin receptor coexpression is associated with poor survival in stage I non-small cell lung cancerClin Cancer Res200713164825483117699861
- Belda-IniestaCPeronaRCarpenoJCHuman recombinant erythropoietin does not promote cancer growth in presence of functional receptors expressed in cancer cellsCancer Biol Ther20076101600160517938574
- McBroomJWAcsGRoseGSKrivakTCMohyeldinAVermaAErythropoietin receptor function and expression in epithelial ovarian carcinomaGynecol Oncol200599357157716051335
- RadesDSetterCDahlOSchildSENoackFPrognostic Impact of erythropoietin expression and erythropoietin receptor expression on locoregional control and survival of patients irradiated for stage ii/iii non-small-cell lung cancerInt J Radiat Oncol Biol Phys201180249950520646855
- RadesDGolkeHSchildSEKilicEThe impact of tumor expression of erythropoietin receptors and erythropoietin on clinical outcome of esophageal cancer patients treated with chemoradiationInt J Radiat Oncol Biol Phys200871115215917967510
- RibattiDMarzulloANicoBCrivellatoERiaRVaccaAErythropoietin as an angiogenic factor in gastric carcinomaHistopathology200342324625012605644
- RibattiDNicoBPerraMTErythropoietin is involved in angiogenesis in human primary melanomaInt J Exp Pathol201091649549920804540
- BrunotteJBockHCBruckWHemmerleinBStrikHHigh expression levels of erythropoietin and its receptor are not correlated with shorter survival in human glioblastomaExp Ther Med20112229529922977501
- LonnrothCSvenssonMWangWSurvival and erythropoietin receptor protein in tumours from patients randomly treated with rhEPO for palliative careMed Oncol2008251222918188711
- MittelbronnMCapperDBunzBDe novo erythropoietin receptor (EPO-R. expression in human neoplastic glial cells decreases with grade of malignancy but is favourably associated with patient survivalNeuropathol Appl Neurobiol200733329930717493011
- PelekanouVKampaMKafousiMErythropoietin and its receptor in breast cancer: correlation with steroid receptors and outcomeCancer Epidemiol Biomarkers Prev200716102016202317932349
- SarteletHFabreMCastaingMExpression of erythropoietin and its receptor in neuroblastomasCancer200711051096110617647284
- Della RagioneFCucciollaVBorrielloAOlivaAPerrottaSErythropoietin receptors on cancer cells: a still open questionJ Clin Oncol200725131812181317470877
- SturialeACampoSCrasciEErythropoietin and its lost receptorNephrol Dial Transplant20072251484148517267537
- LorinczANusserZSpecificity of immunoreactions: the importance of testing specificity in each methodJ Neurosci200828379083908618784286
- LeongASPitfalls in diagnostic immunohistologyAdv Anat Pathol2004112869315090844
- BordeauxJWelshAAgarwalSAntibody validationBiotechniques201048319720920359301
- SaperCBA guide to the perplexed on the specificity of antibodiesJ Histochem Cytochem20095711518854594
- FritschyJMIs my antibody-staining specific? How to deal with pitfalls of immunohistochemistryEur J Neurosci200828122365237019087167
- ElliottSSwiftSBusseLRossiJMcCafferyIAbsence of functional Epo receptors in normal and cancerous human tissues and cell linesBlood2011118213169
- RossiJMcCafferyIPaweletzKAnalysis of cell surface erythropoietin receptor (EpoR) expression and function in human epithelial tumor tissues [abstract]J Clin Oncol20092715SAbstr 11104
- TakeshitaAShinjoKHiguchiMQuantitative expression of erythropoietin receptor (EPO-R) on acute leukaemia cells: relationships between the amount of EPO-R and CD phenotypes, in vitro proliferative response, the amount of other cytokine receptors and clinical prognosis. Japan Adult Leukaemia Study GroupBr J Haematol20001081556310651724
- KokhaeiPAbdallaAOHanssonLExpression of erythropoietin receptor and in vitro functional effects of epoetins in B-cell malignanciesClin Cancer Res200713123536354417575216
- LaMontagneKRButlerJMarshallDJRecombinant epoetins do not stimulate tumor growth in erythropoietin receptor-positive breast carcinoma modelsMol Cancer Ther20065234735516505108
- LiuWMPowlesTShamashJPropperDOliverTJoelSEffect of haemopoietic growth factors on cancer cell lines and their role in chemosensitivityOncogene200423498199014647427
- MitjavilaMTVillevalJLCramerPEffects of granulocyte-macrophage colony-stimulating factor and erythropoietin on leukemic erythroid colony formation in human early erythroblastic leukemiasBlood19877049659733498522
- AsanoYOkamuraSShibuyaTHaradaMNihoYGrowth of clonogenic myeloblastic leukemic cells in the presence of human recombinant erythropoietin in addition to various human recombinant hematopoietic growth factorsBlood1988725168216862460160
- KolonicsAApatiANahajevszkySGatiRBrozikAMagocsiMUnregulated activation of STAT-5, ERK1/2 and c-Fos may contribute to the phenotypic transformation from myelodysplastic syndrome to acute leukaemiaHaematologia200131212513811583024
- OhigashiTYoshiokaKFisherJWAutocrine regulation of erythropoietin gene expression in human hepatocellular carcinoma cellsLife Sci19965854214278594307
- WestenfelderCBaranowskiRLErythropoietin stimulates proliferation of human renal carcinoma cellsKidney Int200058264765710916088
- KitamuraTTojoAKuwakiTIdentification and analysis of human erythropoietin receptors on a factor-dependent cell line, TF-1Blood19897323753802537111
- NakazawaMMitjavilaMTDebiliNKU 812: a pluripotent human cell line with spontaneous erythroid terminal maturationBlood1989737200320132540861
- van ZoelenEJReceptor-ligand interaction: a new method for determining binding parameters without a priori assumptions on non-specific bindingBiochem J198926225495562553000
- PelletierSGingrasSFunakoshi-TagoMHowellSIhleJNTwo domains of the erythropoietin receptor are suff icient for Jak2 binding/activation and functionMol Cell Biol200626228527853816982687
- ShannonAMBouchier-HayesDJCondronCMToomeyDCorrection of anaemia through the use of darbepoetin alfa improves chemotherapeutic outcome in a murine model of Lewis lung carcinomaBr J Cancer200593222423215999100
- FuPJiangXArcasoyMOConstitutively active erythropoietin receptor expression in breast cancer cells promotes cellular proliferation and migration through a MAP-kinase dependent pathwayBiochem Biophys Res Commun2009379369670119133231
- HardeeMECaoYFuPErythropoietin blockade inhibits the induction of tumor angiogenesis and progressionPloS One20076e54917579721
- DunlopEAPercyMJBolandMPMaxwellAPLappinTRInduction of signalling in non-erythroid cells by pharmacological levels of erythropoietinNeurodegener Dis200631–29410016909043
- UmMLodishHFAntiapoptotic effects of erythropoietin in differentiated neuroblastoma SH-SY5Y cells require activation of both the STAT5 and AKT signaling pathwaysJ Biol Chem200628195648565616407271
- LiangKEstevaFJAlbarracinCRecombinant human erythropoietin antagonizes trastuzumab treatment of breast cancer cells via Jak2-mediated Src activation and PTEN inactivationCancer Cell201018542343521075308
- MirmohammadsadeghAMariniAGustrauARole of erythropoietin receptor expression in malignant melanomaJ Invest Dermatol2010130120121019536148
- ArcasoyMOAminKKarayalAFFunctional significance of erythropoietin receptor expression in breast cancerLab Invest200282791191812118093
- HamadmadSNHohlRJErythropoietin stimulates cancer cell migration and activates RhoA protein through a mitogen-activated protein kinase/extracellular signal-regulated kinase-dependent mechanismJ Pharmacol Exp Ther200832431227123318079357
- SinclairAArchibequeIZhanJJanus kinase (JAK) 2 potency and selectivity assessment of small molecules: widely used AG490 inhibitor is neither potent nor selective for JAK2Blood201111821478021868576
- KirkenRAErwinRATaubDTyrphostin AG-490 inhibits cytokine-mediated JAK3/STAT5a/b signal transduction and cellular proliferation of antigen-activated human T cellsJ Leuke Biol1999656891899
- GazitAOsherovNPosnerITyrphostins. 2. Heterocyclic and alpha-substituted benzylidenemalononitrile tyrphostins as potent inhibitors of EGF receptor and ErbB2/neu tyrosine kinasesJ Med Chem1991346189619071676428
- JaleelMShenoyARVisweswariahSSTyrphostins are inhibitors of guanylyl and adenylyl cyclasesBiochem200443258247825515209521
- KaurGGazitALevitzkiAStoweECooneyDASausvilleEATyrphostin induced growth inhibition: correlation with effect on p210bcr-abl autokinase activity in K562 chronic myelogenous leukemiaAnticancer Drugs1994522132228049505
- GewirtzDADiXWalkerTDSawyerSTErythropoietin fails to interfere with the antiproliferative and cytotoxic effects of antitumor drugsClin Cancer Res2006127 Pt 12232223816609039
- FandreyJDicatoMExamining the involvement of erythropoiesis-stimulating agents in tumor proliferation (erythropoietin receptors, receptor binding, signal transduction), angiogenesis, and venous thromboembolic eventsOncologist200914Suppl 1344219762515
- AmmarguellatFLloveraMKellyPAGoffinVLow doses of EPO activate MAP kinases but not JAK2-STAT5 in rat vascular smooth muscle cellsBiochem Biophys Res Commun200128441031103811409898
- HardeeMECaoYFuPErythropoietin blockade inhibits the induction of tumor angiogenesis and progressionPloS One20076e54917579721
- LesterRDJoMCampanaWMGoniasSLErythropoietin promotes MCF-7 breast cancer cell migration by an ERK/mitogen-activated protein kinase-dependent pathway and is primarily responsible for the increase in migration observed in hypoxiaJ Biol Chem200528047392733927716207704
- SeidelHMLambPRosenJPharmaceutical intervention in the JAK/ STAT signaling pathwayOncogene200019212645265610851064
- JatianiSSBakerSJSilvermanLRPremkumarREJAK/STAT pathways in cytokine signaling and myeloproliferative disorders: approaches for targeted therapiesGenes Cancer201011097999321442038
- ParganasEWangDStravopodisDJak2 is essential for signaling through a variety of cytokine receptorsCell19989333853959590173
- SwiftSElliottSSinclairABegleyCGErythropoietin receptor in ovarian cancer cells – LetterMol Cancer Ther2010941070107120371727
- HsuRYChanCHSpicerJDLPS-induced TLR4 signaling in human colorectal cancer cells increases beta1 integrin-mediated cell adhesion and liver metastasisCancer Res20117151989199821363926
- DoanHQBowenKAJacksonLAEversBMToll-like receptor 4 activation increases Akt phosphorylation in colon cancer cellsAnticancer Res20092972473247819596916
- KeenanJDooleyMPearsonDClynesMRecombinant human albumin in cell culture: evaluation of growth-promoting potential for NRK and SCC-9 cells in vitroCytotechnology199624243252
- SlaabyRAndersenASBrandtJIGF-I binding to the IGF-I receptor is affected by contaminants in commercial BSA: the contaminants are proteins with IGF-I binding propertiesGrowth Horm IGF Res200818426727417945524
- EthertonTDChungCSWigginsJPReceptor-dependent and independent degradation of insulin by isolated swine adipocytes at 37 CJ Anim Sci19845923663756384170
- BlairKJKiangAWang-RodriguezJYuMADohertyJKOngkekoWMEGF and bFGF promote invasion that is modulated by PI3/ Akt kinase and Erk in vestibular schwannomaOtol Neurotol201132230831421178801
- HassounaISperlingSKimEErythropoietin augments survival of glioma cells after radiation and temozolomideInt J Radiat Oncol Biol Phys200872392793419014782
- LaMontagneKRButlerJMarshallDJRecombinant epoetins do not stimulate tumor growth in erythropoietin receptor-positive breast carcinoma modelsMol Cancer Ther20065234735516505108
- QuesenberryPLevinJZuckermanKRencriccaNSullivanRTylerWStem cell migration induced by erythropoietin or haemolytic anaemia: the effects of actinomycin and endotoxin contamination of erythropoietin preparationsBr J Haematol197941225326985457
- HarmeyJHBucanaCDLuWLipopolysaccharide-induced metastatic growth is associated with increased angiogenesis, vascular permeability and tumor cell invasionInt J Cancer2002101541542212216068
- KilleenSDWangJHAndrewsEJRedmondHPBacterial endotoxin enhances colorectal cancer cell adhesion and invasion through TLR-4 and NF-kappaB-dependent activation of the urokinase plasminogen activator systemBr J Cancer2009100101589160219436306
- WangJHManningBJWuQDBlanksonSBouchier-HayesDRedmondHPEndotoxin/lipopolysaccharide activates NF-kappa B and enhances tumor cell adhesion and invasion through a beta 1 integrin-dependent mechanismJ Immunol2003170279580412517943
- SugawaMFukuiHEffects of recombinant human erythropoietin on the growth of various human tumor cellsBiotherapy2005192181196
- BauerEDanhauser-RiedlSDeRWEffects of recombinant human erythropoietin on clonogenic growth of primary human tumour specimens in vitroEur J Cancer199228A1017691389501
- MillerCPValliant-SaundersKBlauCALimitations of a murine transgenic breast cancer model for studies of erythropoietin-induced tumor progressionClin Transl Oncol201033176180
- YasudaYMushaTTanakaHInhibition of erythropoietin signal-ling destroys xenografts of ovarian and uterine cancers in nude miceBr J Cancer200184683684311259101
- YarkoniEGorenMBRappHJRegression of a transplanted guinea pig hepatoma after intralesional injection of an emulsified mixture of endotoxin and mycobacterial sulfolipidInfect Immun1979242357362378852
- VillevalJLMitjavilaMTDusanter-FourtIWendlingFMayeuxPVainchenkerWAutocrine stimulation by erythropoietin (Epo) requires Epo secretionBlood1994848264926627919379
- RaskoJEMetcalfDGoughNMBegleyCGThe cytokine receptor repertoire specifies autocrine growth factor production in factor-dependent cellsExp Hematol19952354534607720817
- PalumboCBattistiSCarboneDRecombinant erythropoietin differently affects proliferation of mesothelioma cells but not sensitivity to cisplatin and pemetrexedCancer Chemother Pharmacol200861589390117922127
- AcsGChenMXuXAcsPVermaAKochCJAutocrine erythropoietin signaling inhibits hypoxia-induced apoptosis in human breast carcinoma cellsCancer Lett2004214224325115363551
- KumarSMAcsGFangDHerlynMElderDEXuXFunctional erythropoietin autocrine loop in melanomaAm J Pathol2005166382383015743794
- HankinsWDSchooleyJEastmentCErythropoietin, an autocrine regulator? Serum-free production of erythropoietin by cloned erythroid cell linesBlood19866812632683459557
- QianRLChinKKimJKChinHMConeJHankinsWDPurification of murine erythropoietin produced in serum-free cultures of erythro-leukemia cellsBlood19866812582623459556
- MitjavilaMTLe CouedicJPCasadevallNAutocrine stimulation by erythropoietin and autonomous growth of human erythroid leukemic cells in vitroJ Clin lnvest1991883789797
- SherwoodJBShouvalDContinuous production of erythropoietin by an established human renal carcinoma cell line: development of the cell lineProc Natl Acad Sci U S A19868311651693455754
- ShouvalDSherwoodJBProduction of erythropoietin by an established human renal carcinoma cell line: in vitro and in vivo studiesAdv Exp Med Biol19882413193283223410
- HammondDWinnickSParaneoplastic erythrocytosis and ectopic erythropoietinsAnn N Y Acad Sci19742302192274595944
- KaelinWGJrThe von Hippel-Lindau tumour suppressor protein: O2 sensing and cancerNat Rev Cancer200881186587318923434
- BerdelWEDanhauser-RiedlSOberbergDZafferaniMEffects of hematopoietic growth factors on malignant nonhematopoietic cellsSemin Oncol1992192 Suppl 441451553574
- HamamoriYSamalBTianJKedesLPersistent erythropoiesis by myoblast transfer of erythropoietin cDNAHum Gene Ther1994511134913567893806
- MuramatsuTArakawaSFukazawaKIn vivo gene electroporation in skeletal muscle with special reference to the duration of gene expressionInt J Mol Med200171374211115606
- GeudensIGerhardtHCoordinating cell behaviour during blood vessel formationDevelopment2011138214569458321965610
- WuHLeeSHGaoJLiuXIruela-ArispeMLInactivation of erythropoietin leads to defects in cardiac morphogenesisDevelopment1999126163597360510409505
- KerteszNWuJChenTHSucovHMWuHThe role of erythropoietin in regulating angiogenesisDev Biol2004276110111015531367
- DavidoffAMNgCYBrownPBone marrow-derived cells contribute to tumor neovasculature and, when modified to express an angiogenesis inhibitor, can restrict tumor growth in miceClin Cancer Res2001792870287911555605
- DePalmaMNaldiniLRole of haematopoietic cells and endothelial progenitors in tumour angiogenesisBiochim Biophys Acta20061766115916616857321
- ZwezdarykKJCoffeltSBFigueroaYGErythropoietin, a hypoxia-regulated factor, elicits a pro-angiogenic program in human mesenchymal stem cellsExp Hematol2007354640652 [Erratum, Exp Hematol. 2007;35(7):1153–1161]17379074
- HaoQLiuJRPappuRContribution of bone marrow-derived cells associated with brain angiogenesis is primarily through leukocytes and macrophagesArterioscler Thromb Vasc Biol200828122151215718802012
- Muller-EhmsenJSchmidtAKrausgrillBSchwingerRHBlochWRole of erythropoietin for angiogenesis and vasculogenesis: from embryonic development through adulthoodAm J Physiol Heart Circ Physiol20062901H331H34016024562
- PerryTESongMDespresDJBone marrow-derived cells do not repair endothelium in a mouse model of chronic endothelial cell dysfunctionCardiovasc Res200984231732519578071
- ScherschelJASoonpaaMHSrourEFFieldLJRubartMAdult bone marrow-derived cells do not acquire functional attributes of cardiomyocytes when transplanted into peri-infarct myocardiumMol Ther20081661129113718431364
- GothertJRGustinSEvan EekelenJAGenetically tagging endothelial cells in vivo: bone marrow-derived cells do not contribute to tumor endotheliumBlood200410461769177715187022
- ZiegelhoefferTFernandezBKostinSBone marrow-derived cells do not incorporate into the adult growing vasculatureCirc Res200494223023814656934
- CrivellatoENicoBVaccaADjonovVPrestaMRibattiDRecombinant human erythropoietin induces intussusceptive microvascular growth in vivoLeukemia200418233133614671634
- JaquetKKrauseKTawakol-KhodaiMGeidelSKuckKHErythropoietin and VEGF exhibit equal angiogenic potentialMicrovasc Res200264232633312204656
- BahlmannFHDeGrootKDuckertTEndothelial progenitor cell proliferation and differentiation is regulated by erythropoietinKidney Int20036451648165214531796
- BahlmannFHSongRBoehmSMLow-dose therapy with the long-acting erythropoietin analogue darbepoetin alpha persistently activates endothelial Akt and attenuates progressive organ failureCirculation200411081006101215302785
- HeeschenCAicherALehmannRErythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilizationBlood200310241340134612702503
- PerrottaSCucciollaVFerraroMEPO receptor gain-of-function causes hereditary polycythemia, alters CD34 cell differentiation and increases circulating endothelial precursorsPloS One2010582010
- DuffSELiCGarlandJMKumarSCD105 is important for angiogenesis: evidence and potential applicationsFASEB J200317998499212773481
- BuhringHJMullerCALetarteMEndoglin is expressed on a subpopulation of immature erythroid cells of normal human bone marrowLeukemia19915108418471961019
- KimSNMoonJHKimJGMobilization effects of G-CSF, GM-CSF, and darbepoetin-alpha for allogeneic peripheral blood stem cell transplantationJ Clin Apher200924517317919753648
- TaniguchiNSawadaTMatsubaraKErythropoietin prevention trial of coronary restenosis and cardiac remodeling after ST-elevated acute myocardial infarction (EPOC-AMI): a pilot, randomized, placebo-controlled studyCirc J201074112365237120834185
- PawlakKPawlakDMysliwiecMLong-term erythropoietin therapy does not affect endothelial markers, coagulation activation and oxidative stress in haemodialyzed patientsThromb Res2007120679780317391740
- TsuzukiMBone marrow-derived cells are not involved in reendothelialized endothelium as endothelial cells after simple endothelial denudation in miceBasic Res Cardiol2009104560161119333644
- PetersBADiazLAPolyakKContribution of bone marrow-derived endothelial cells to human tumor vasculatureNat Med200511326126215723071
- MacheinMRRenningerSde Lima-HahnEPlateKHMinor contribution of bone marrow-derived endothelial progenitors to the vascularization of murine gliomasBrain Pathol200313458259714655762
- SuzukiNOhnedaOTakahashiSErythroid-specific expression of the erythropoietin receptor rescued its null mutant mice from lethalityBlood200210072279228812239135
- AmmarguellatFGogusevJDruekeTBDirect effect of erythropoietin on rat vascular smooth-muscle cell via a putative erythropoietin receptorNephrol Dial Transplant19961146876928671860
- Lopez OngilSLSauraMLamasSRodriguezPMRodriguezPDRecombinant human erythropoietin does not regulate the expression of endothelin-1 and constitutive nitric oxide synthase in vascular endothelial cellsExp Nephrol19964137428788598
- FusteBaz-RicartMCasesALopez-PedretJOrdinasAEscolarGErythropoietin does not modify the prothrombotic effect induced by uremic media on endothelial cellsHaematologica20028791006100812217816
- HardeeMEKirkpatrickJPShanSHuman recombinant erythropoietin (rEpo) has no effect on tumour growth or angiogenesisBr J Cancer200593121350135516288305
- SairahAKRasedeeASheikhORozitaRALHajNThe effects of recombinant human erythropoietin and tamoxifen on growth and angiogenesis of mammary tumor in Sprague-Dawley ratAm J Pharmacol Toxicol2009411216
- PinelSBarberi-HeyobMCohen-JonathanEErythropoietin-induced reduction of hypoxia before and during fractionated irradiation contributes to improvement of radioresponse in human glioma xenograftsInt J Radiat Oncol Biol Phys200459125025915093922
- YamajiROkadaTMoriyaMBrain capillary endothelial cells express two forms of erythropoietin receptor mRNAEur J Biochem199623924945008706759
- AnagnostouALeeESKessimianNLevinsonRSteinerMErythropoietin has a mitogenic and positive chemotactic effect on endothelial cellsProc Natl Acad Sci U S A19908715597859822165612
- RibattiDPrestaMVaccaAHuman erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivoBlood19999382627263610194442
- NicoBAnneseTGuidolinDFinatoNCrivellatoERibattiDEpo is involved in angiogenesis in human gliomaJ Neurooncol20111021515820614229
- SamarutJNigonVIn vitro development of chicken erythropoietin-sensitive cellsExp Cell Res19761002245248945769
- SteinleinPDeinerELeutzABeugHRecombinant murine erythropoietin receptor expressed in avian erythroid progenitors mediates terminal erythroid differentiation in vitroGrowth Factors19941011168179929
- KooBCKwonMSLeeHTetracycline-dependent expression of the human erythropoietin gene in transgenic chickensTransgenic Res201019343744719795218
- YuXShackaJJEellsJBErythropoietin receptor signalling is required for normal brain developmentDevelopment2002129250551611807041
- SatohKKagayaYNakanoMImportant role of endogenous erythropoietin system in recruitment of endothelial progenitor cells in hypoxia-induced pulmonary hypertension in miceCirculation2006113111442145016534010
- NakanoMSatohKFukumotoYImportant role of erythropoietin receptor to promote VEGF expression and angiogenesis in peripheral ischemia in miceCirc Res2007100566266917293480
- CalvilloLLatiniRKajsturaJRecombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodelingProc Natl Acad Sci U S A200310084802480612663857
- MoonCKrawczykMAhnDErythropoietin reduces myocardial infarction and left ventricular functional decline after coronary artery ligation in ratsProc Natl Acad Sci U S A200310020116121161714500913
- TramontanoAFMuniyappaRBlackADErythropoietin protects cardiac myocytes from hypoxia-induced apoptosis through an Akt-dependent pathwayBiochem Biophys Res Commun2003308499099412927817
- BakerJEKozikDHsuAKFuXTweddellJSGrossGJDarbepoetin alfa protects the rat heart against infarction: dose-response, phase of action, and mechanismsJ Cardiovasc Pharmacol200749633734517577097
- ParsaCJKimJRielRUCardioprotective effects of erythropoietin in the reperfused ischemic heart: a potential role for cardiac fibroblastsJ Biol Chem200427920206552066215020586
- AsaumiYKagayaYTakedaMProtective role of endogenous erythropoietin system in nonhematopoietic cells against pressure overload-induced left ventricular dysfunction in miceCirculation2007115152022203217404160
- TadaHKagayaYTakedaMEndogenous erythropoietin system in non-hematopoietic lineage cells plays a protective role in myocardial ischemia/reperfusionCardiovasc Res200671346647716781691
- SirenALFratelliMBrinesMErythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stressProc Natl Acad Sci U S A20019874044404911259643
- SakanakaMWenTCMatsudaSIn vivo evidence that erythropoietin protects neurons from ischemic damageProc Natl Acad Sci U S A1998958463546409539790
- GorioAGokmenNErbayraktarSRecombinant human erythropoietin counteracts secondary injury and markedly enhances neurological recovery from experimental spinal cord traumaProc Natl Acad Sci U S A200299149450945512082184
- SalahudeenAKHaiderNJenkinsJAntiapoptotic properties of erythropoiesis-stimulating proteins in models of cisplatin- induced acute kidney injuryAm J Physiol Renal Physiol20082946F1354F136518385271
- BahlmannFHFliserDErythropoietin and renoprotectionCurr Opin Nephrol Hypertens2009181152019077684
- LombarderoMKovacsKScheithauerBWErythropoietin: a hormone with multiple functions [review]Pathobiology2011781415321474975
- ArcasoyMOThe non-haematopoietic biological effects of erythropoietinBr J Haematol20081411143118324962
- MinhKLKlemmKAbshagenKEipelCMengerMDVollmarBAttenuation of inflammation and apoptosis by pre- and posttreatment of darbepoetin-alpha in acute liver failure of miceAm J Pathol200717061954196317525263
- SepodesBMaioRPintoRRecombinant human erythropoietin protects the liver from hepatic ischemia-reperfusion injury in the ratTranspl Int2006191191992617018128
- KatavetinPTungsangaKEiam-OngSNangakuMAntioxidative effects of erythropoietinKidney Int200772Suppl 107S10S15
- MartiHHGassmannMWengerRHDetection of erythropoietin in human liquor: intrinsic erythropoietin production in the brainKidney Int19975124164189027715
- BanksWAJumbeNLFarrellCLNiehoffMLHeatheringtonACPassage of erythropoietic agents across the blood-brain barrier: a comparison of human and murine erythropoietin and the analog darbepoetin alfaEur J Pharmacol20045051–39310115556141
- JuulSEHarcumJLiYChristensenRDErythropoietin is present in the cerebrospinal fluid of neonatesJ Pediatr199713034284309063419
- TsaiPTOhabJJKerteszNA critical role of erythropoietin receptor in neurogenesis and post-stroke recoveryJ Neurosci20062641269127416436614
- ChenXChenYBiYPreventive cardioprotection of erythropoietin against doxorubicin-induced cardiomyopathyCardiovasc Drugs Ther200721536737417924179
- JuulSEYachnisATChristensenRDTissue distribution of erythropoietin and erythropoietin receptor in the developing human fetusEarly Hum Dev19985232352499808074
- WestenfelderCBiddleDLBaranowskiRLHuman, rat, and mouse kidney cells express functional erythropoietin receptorsKidney Int199955380882010027918
- CaiZManaloDJWeiGHearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injuryCirculation20031081798512796124
- BrinesMGrassoGFiordalisoFErythropoietin mediates tissue protection through an erythropoietin and common beta-subunit heteroreceptorProc Natl Acad Sci U S A200410141149071491215456912
- AgarwalNGordeukVRPrchalJTAre erythropoietin receptors expressed in tumors? Facts and fiction – more careful studies are neededJ Clin Oncol200725131813181417470878
- ParsaCJMatsumotoAKimJA novel protective effect of erythropoietin in the infarcted heartJ Clin Invest20031127999100714523037
- AkimotoTKusanoEInabaTErythropoietin regulates vascular smooth muscle cell apoptosis by a phosphatidylinositol 3 kinase-dependent pathwayKidney Int200058126928210886572
- FiordalisoFChimentiSStaszewskyLA nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia-reperfusion injuryProc Natl Acad Sci U S A200510262046205115671158
- ZhangDZhangFZhangYErythropoietin enhances the angiogenic potency of autologous bone marrow stromal cells in a rat model of myocardial infarctionCardiology2007108422823617106196
- RuscherKFreyerDKarschMErythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro modelJ Neurosci20022223102911030112451129
- YangCWLiCJungJYPreconditioning with erythropoietin protects against subsequent ischemia-reperfusion injury in rat kidneyFASEB J200317121754175512958199
- VeseyDACheungCPatBEndreZGobeGJohnsonDWErythropoietin protects against ischaemic acute renal injuryNephrol Dial Transplant200419234835514736958
- NemotoTYokotaNKeaneWFRabbHRecombinant erythropoietin rapidly treats anemia in ischemic acute renal failureKidney Int200159124625111135077
- KohSHKimYKimHYChoGWKimKSKimSHRecombinant human erythropoietin suppresses symptom onset and progression of G93A-SOD1 mouse model of ALS by preventing motor neuron death and inflammationEur J Neurosci20072571923193017439481
- GrunfeldJFBarhumYBlondheimNRabeyJMMelamedEOffenDErythropoietin delays disease onset in an amyotrophic lateral sclerosis modelExp Neurol2007204126026317174305
- GrignaschiGZennaroETortaroloMCalvaresiNBendottiCErythropoietin does not preserve motor neurons in a mouse model of familial ALSAmyotroph Lateral Scler200781313517364433
- AgnelloDBiginiPVillaPErythropoietin exerts an anti- inflammatory effect on the CNS in a model of experimental autoimmune encephalomyelitisBrain Res2002952112813412363412
- BrendtPFreyUAdamzikMSchaferSTPetersJDarbepoetin alpha, a long-acting erythropoeitin derivate, does not alter LPS evoked myocardial depression and gene expression of Bax, Bcl-Xs, Bcl-XL, Bcl-2, and TNF-alphaShock2009311505418497705
- SpreerAGerberJHanssenMNauRNo neuroprotective effect of erythropoietin under clinical treatment conditions in a rabbit model of Escherichia coli meningitisPediatr Res200762668068317957150
- SøllingCOrgan-protective and immunomodulatory effects of erythropoietin – an update on recent clinical trialsBasic Clin Pharmacol Toxicol20121102113121
- EhrenreichHWeissenbornKPrangeHRecombinant human erythropoietin in the treatment of acute ischemic strokeStroke20094012e647e65619834012
- SpringborgJBMollerCGideonPJorgensenOSJuhlerMOlsenNVErythropoietin in patients with aneurysmal subarachnoid haemorrhage: a double blind randomised clinical trialActa Neurochir (Wien)2007149111089110017876497
- TalvingPLustenbergerTKobayashiLErythropoiesis stimulating agent administration improves survival after severe traumatic brain injury: a matched case control studyAnn Surg201025111419779323
- BinbrekASRaoNSAlKNAssaqqafJSobelBEErythropoietin to augment myocardial salvage induced by coronary thrombolysis in patients with ST segment elevation acute myocardial infarctionAm J Cardiol200981035104019801020
- ClelandJGColettaAPClarkALCullingtonDClinical trials update from the American College of Cardiology 2009: ADMIRE-HF, PRIMA, STICH, REVERSE, IRIS, partial ventricular support, FIX-HF- 5, vagal stimulation, REVIVAL-3, pre-RELAX-AHF, ACTIVE-A, HF-ACTION, JUPITER, AURORA, and OMEGAEur J Heart Fail200911662263019468023
- FerrarioMArbustiniEMassaMHigh-dose erythropoietin in patients with acute myocardial infarction: a pilot, randomised, placebo-controlled studyInt J Cardiol2011147112413119906454
- NajjarSSRaoSVMelloniCIntravenous erythropoietin in patients with ST-segment elevation myocardial infarction: REVEAL: a randomized controlled trialJAMA2011305181863187221558517
- OttISchulzSMehilliJErythropoietin in patients with acute st-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention a randomized, double-blind trialCirc Cardiovasc Interv20103540841320736448
- RaoSVKilaruRPovsicTJA randomized placebo controlled trial of intravenous erythropoietin to reduce infarct size after st-segment elevation myocardial infarction: primary results of the REVEAL trialCirculation2010122212222
- VoorsAABelonjeAMZijlstraFA single dose of erythropoietin in ST-elevation myocardial infarctionEur Heart J201031212593260020802250
- BeckerBNBeckerYTLeversonGEHeiseyDMErythropoietin therapy may retard progression in chronic renal transplant dysfunctionNephrol Dial Transplant20021791667167312198221
- HaferCBeckerTKielsteinJTHigh-dose erythropoietin has no effect on short-or long-term graft function following deceased donor kidney transplantationKidney Int201281331432022012130
- KamarNRebouxA-HCointaultOImpact of very early high doses of recombinant erythropoietin on anemia and allograft function in de novo kidney-transplant patientsTranspl Int201023327728419821956
- MartinezFKamarNPalletNHigh dose epoetin beta in the first weeks following renal transplantation and delayed graft function: results of the Neo-PDGF study [brief communication]Am J Transplant201010717041709
- EndreZHWalkerRJPickeringJWEarly intervention with erythropoietin does not affect the outcome of acute kidney injury (the EARLYARF trial)Kidney Int201077111020103020164823
- ParkJGageBFVijayanAUse of EPO in critically ill patients with acute renal failure requiring renal replacement therapyAmerican Journal of Kidney Diseases200546579179816253718
- SongYRLeeTYouSJPrevention of acute kidney injury by erythropoietin in patients undergoing coronary artery bypass grafting: a pilot studyAm J Nephrol200930325326019494484
- ChristensenBLundbyCJessenNEvaluation of functional erythropoietin receptor status in skeletal muscle in vivo: acute and prolonged studies in healthy human subjectsPloS One201272e3185722384088
- LeistMGhezziPGrassoGDerivatives of erythropoietin that are tissue protective but not erythropoieticScience2004305568123924215247477
- MoonCKrawczykMPaikDErythropoietin, modified to not stimulate red blood cell production, retains its cardioprotective propertiesJ Pharmacol Exp Ther20063163999100516306273
- ImamuraRIsakaYIchimaruNTakaharaSOkuyamaACarbamylated erythropoietin protects the kidneys from ischemia-reperfusion injury without stimulating erythropoiesisBiochem Biophys Res Commun2007353378679217196938
- ImamuraROkumiMIsakaYCarbamylated erythropoietin improves angiogenesis and protects the kidneys from ischemia-reperfusion injuryCell Transplant2008171–213514118468243
- KitamuraHIsakaYTakabatakeYNonerythropoietic derivative of erythropoietin protects against tubulointerstitial injury in a unilateral ureteral obstruction modelNephrol Dial Transplant20082351521152818194980
- KingVRAverillSAHewazyDPriestleyJVTorupLMichael-TitusATErythropoietin and carbamylated erythropoietin are neuroprotective following spinal cord hemisection in the ratEur J Neurosci20072619010017614942
- MonteroMPoulsenFRNorabergJComparison of neuroprotective effects of erythropoietin (EPO) and carbamylerythropoietin (CEPO) against ischemia-like oxygen-glucose deprivation (OGD) and NMDA excitotoxicity in mouse hippocampal slice culturesExp Neurol2007204110611717157835
- SchmidtREGreenKGFengDErythropoietin and its carbamylated derivative prevent the development of experimental diabetic autonomic neuropathy in STZ-induced diabetic NOD-SCID miceExp Neurol2008209116117017967455
- RobbLDrinkwaterCCMetcalfDHematopoietic and lung abnormalities in mice with a null mutation of the common beta subunit of the receptors for granulocyte-macrophage colony-stimulating factor and interleukins 3 and 5Proc Natl Acad Sci U S A19959221956595697568173
- NicolaNARobbLMetcalfDCaryDDrinkwaterCCBegleyCGFunctional inactivation in mice of the gene for the interleukin-3 (IL-3)- specific receptor beta-chain: implications for IL-3 function and the mechanism of receptor transmodulation in hematopoietic cellsBlood1996877266526748639882
- ScottCLHughesDACaryDNicolaNABegleyCGRobbLFunctional analysis of mature hematopoietic cells from mice lacking the betac chain of the granulocyte-macrophage colony-stimulating factor receptorBlood19989211411941279834217
- ScottCLRobbLPapaevangeliouBMansfieldRNicolaNABegleyCGReassessment of interactions between hematopoietic receptors using common beta-chain and interleukin-3-specific receptor beta-chain-null cells: no evidence of functional interactions with receptors for erythropoietin, granulocyte colony-stimulating factor, or stem cell factorBlood20009641588159010942411
- MittelmanMNeumannDPeledAKanterPHaran-GheraNErythropoietin induces tumor regression and antitumor immune responses in murine myeloma modelsProc Natl Acad Sci U S A20019895181518611309490
- MittelmanMThe implications of anemia in multiple myelomaClin Lymphoma20034Suppl 1S23S2914556675
- StubenGThewsOPottgenCImpact of anemia prevention by recombinant human erythropoietin on the sensitivity of xenografted glioblastomas to fractionated irradiationStrahlenther Onkol2003179962062514628128
- SigounasGSallahSSigounasVYErythropoietin modulates the anticancer activity of chemotherapeutic drugs in a murine lung cancer modelCancer Lett2004214217117915363543
- ThewsOKoenigRKelleherDKKutznerJVaupelPEnhanced radiosensitivity in experimental tumours following erythropoietin treatment of chemotherapy-induced anaemiaBr J Cancer19987867527569743294
- SilverDFPiverMSEffects of recombinant human erythropoietin on the antitumor effect of cisplatin in SCID mice bearing human ovarian cancer: a possible oxygen effectGynecol Oncol199973228028410329047
- StubenGThewsOPottgenCKnuhmannKVaupelPStuschkeMRecombinant human erythropoietin increases the radiosensitivity of xenografted human tumours in anaemic nude miceJ Cancer Res Clin Oncol2001127634635011414194
- ThewsOKelleherDKVaupelPErythropoietin restores the anemia-induced reduction in cyclophosphamide cytotoxicity in rat tumorsCancer Res20016141358136111245434
- GolabJOlszewskaDMrozPErythropoietin restores the antitumor effectiveness of photodynamic therapy in mice with chemotherapy- induced anemiaClin Cancer Res2002851265127012006547
- TovariJGillyRRasoERecombinant human erythropoietin alpha targets intratumoral blood vessels, improving chemotherapy in human xenograft modelsCancer Res200565167186719316103069
- LoveyJBereczkyBGillyRRecombinant human erythropoietin alpha improves the efficacy of radiotherapy of a human tumor xenograft, affecting tumor cells and microvesselsStrahlenther Onkol200818411718188516
- GolabJZagozdzonRStoklosaTJakobisiakMPojdaZMachajEErythropoietin prevents the development of interleukin-12-induced anemia and thrombocytopenia but does not decrease its antitumor activity in miceBlood19989111438743889596689
- BlackwellKLKirkpatrickJPSnyderSAHuman recombinant erythropoietin significantly improves tumor oxygenation independent of its effects on hemoglobinCancer Res200363196162616514559797
- BianchiRGilardiniARodriguez-MenendezVCisplatin-induced peripheral neuropathy: neuroprotection by erythropoietin without affecting tumour growthEur J Cancer200743471071717251006
- KelleherDKMattheinsenUThewsOVaupelPBlood flow, oxygenation, and bioenergetic status of tumors after erythropoietin treatment in normal and anemic ratsCancer Res19965620472847348840991
- KirkpatrickJPHardeeMESnyderSAThe effect of darbepoetin alfa on growth, oxygenation and radioresponsiveness of a breast adenocarcinomaRadiat Res2006165219220116518899
- van HalterenHKBongaertsGPVerhagenCARecombinant human erythropoietin attenuates weight loss in a murine cancer cachexia modelJ Cancer Res Clin Oncol2004130421121614745550
- HardeeMERabbaniZNArcasoyMOErythropoietin inhibits apoptosis in breast cancer cells via an Akt-dependent pathway without modulating in vivo chemosensitivityMol Cancer Ther20065235636116505109
- KjellenESasakiYKjellstromJZackrissonBWennerbergJRecombinant erythropoietin beta enhances growth of xenografted human squamous cell carcinoma of the head and neck after surgical traumaActa Otolaryngol2006126554554716698707
- OkazakiTEbiharaSAsadaMYamandaSNiuKAraiHErythropoietin promotes the growth of tumors lacking its receptor and decreases survival of tumor-bearing mice by enhancing angiogenesisNeoplasia200810993293918714393
- RupertusKSperlingJCorstenMDarbepoetin-alpha enhances hepatectomy-associated stimulation of colorectal liver metastatic growthAnn Surg2010252113114120531003
- MirabelliPDiNRLoPCExtended flow cytometry characterization of normal bone marrow progenitor cells by simultaneous detection of aldehyde dehydrogenase and early hematopoietic antigens: implication for erythroid differentiation studiesBMC Physiol200881318510759
- KomatsuNYamamotoMFujitaHEstablishment and characterization of an erythropoietin-dependent subline, UT-7/Epo, derived from human leukemia cell line, UT-7Blood19938224564648329702